Natco Pharma approves rights issue to raise up to ₹1,279 crore
By United One News · AI-generated summary of 1 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below: Natco Pharma’s board has approved a rights issue that will allow the company to issue up to 1,70,58,082 equity shares at ₹750 each, with a face value of ₹2 per share. The offering is expected to raise no more than ₹1,279.35 crore. The move is intended to strengthen the company’s balance sheet and support future growth initiatives.
Covered by 2 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Zelio E-Mobility to raise ₹168 crore via preferential issue for expansion, Haryana plant development
Timeline
First reported by The Hindu BusinessLine on ; 2 articles from 1 outlets so far.
Who is covering this story
- Center (1): The Hindu BusinessLine
Sources
- Zelio E-Mobility to raise ₹168 crore via preferential issue for expansion, Haryana plant development — The Hindu BusinessLine (center, AI-estimated) ·
- Natco Pharma board approves rights issue to raise up to ₹1,279 crore — The Hindu BusinessLine (center, AI-estimated) ·